RRAS Gene - RAS Related Protein

Comprehensive genomic and functional analysis of RRAS, a member of the RAS superfamily of small GTPases involved in cell signaling, growth, and cancer.

Gene Information Card

Symbol RRAS
Full Name RAS related protein
Gene Type protein coding
Chromosomal Location 19q13.33
NCBI Gene ID 6237 ncbi.nlm.nih.gov/gene/6237
Ensembl ID ENSG00000105699
UniProt ID P10301
OMIM ID 165090
HGNC ID 10447
Aliases R-Ras, p23, R-Ras2

Description

RRAS (RAS related protein) encodes a member of the RAS subfamily of small GTPases. The protein functions as a molecular switch in signal transduction pathways, regulating cell adhesion, migration, proliferation, and survival. It is involved in integrin signaling and cytoskeletal reorganization. Mutations in RRAS are associated with Noonan syndrome and various cancers, including lung adenocarcinoma and melanoma.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Noonan syndrome Gain-of-function mutations in RRAS lead to aberrant activation of the RAS-MAPK signaling pathway, disrupting normal development. ClinVar, OMIM
Lung adenocarcinoma Somatic mutations (e.g., G12V) result in constitutive activation of RRAS, promoting uncontrolled cell proliferation. COSMIC, NCBI
Melanoma RRAS overexpression and activating mutations contribute to tumor growth and metastasis via enhanced integrin signaling. COSMIC, UniProt

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Lung 15.2 Medium
Liver 6.1 Low
Kidney 9.8 Low
Testis 20.4 High
Cell Line Expression
Cell Line nTPM Notes
A549 (lung carcinoma) 18.7 High expression
MCF7 (breast carcinoma) 7.2 Low expression
HEK293 (embryonic kidney) 10.5 Medium expression
SK-MEL-28 (melanoma) 22.1 High expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
G12V Substitution <1% Activating mutation; constitutive GTP binding, increased downstream signaling.
G38R Substitution <0.5% Gain-of-function; associated with Noonan syndrome.
Q87L Substitution <0.1% Activating mutation; impaired GTP hydrolysis.
T87I Substitution <0.1% Likely gain-of-function; reported in melanoma.
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in RRAS; most mutations are activating.

Gain of Function (GOF)

G12V, G38R, Q87L, and T87I are gain-of-function mutations that increase GTP-bound active state, enhancing RAS-MAPK signaling.

Dominant Negative (DN)

No dominant-negative mutations have been described for RRAS.

Gene Ontology (GO)

• GTP binding • GTPase activity
• signal transduction • cell adhesion
• cell migration • regulation of cell proliferation
• integrin-mediated signaling pathway • RAS protein signal transduction

Pathways

RAS signaling pathway
MAPK signaling pathway
Integrin signaling pathway
Regulation of actin cytoskeleton

Protein Summary

RRAS is a 218-amino acid small GTPase (UniProt P10301) that cycles between an active GTP-bound and inactive GDP-bound state. It localizes to the plasma membrane and endosomes, where it regulates cell adhesion, spreading, and migration through interactions with integrins and effectors such as RALGDS and PI3K. RRAS is ubiquitously expressed with highest levels in testis and brain. Activating mutations are oncogenic and linked to Noonan syndrome.

Related Products

Product name Cat.No. Species Gene ID
RRAS2 Knockout HEK293 Cell Line EDJ-KQ755 Human 22800 Details Get a Quote
RRAS Knockout HEK293 Cell Line EDJ-KQ1226 Human 6237 Details Get a Quote
RRAS2 Knockout HeLa Cell Line EDJ-KQ18253 Human 22800 Details Get a Quote
RRAS2 Knockout A-549 Cell Line EDJ-KQ19417 Human 22800 Details Get a Quote
RRAS2 Knockout HCT 116 Cell Line EDJ-KQ19418 Human 22800 Details Get a Quote
RRAS Knockout A-549 Cell Line EDJ-KQ20558 Human 6237 Details Get a Quote
RRAS Knockout HCT 116 Cell Line EDJ-KQ20559 Human 6237 Details Get a Quote
RRAS Knockout HeLa Cell Line EDJ-KQ20560 Human 6237 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: